Nivolumab,Relatlimab
BMS
['nivolumab', 'nivo', 'melanoma', 'relatlimab']
research nurse suzanne phillips shared insights on a phase ii study of nivolumab in combination with relatlimab in patients with active melanoma brain metastases (tps9605). #asco23 #melanoma #endcancer (7/9) 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789